Weekly round-up #254
Watch Now - VALIDATE Seminar: A Double Bill with Institut Pasteur de Tunis
On 25 January, we held our first Seminar of 2023. Watch both talks on our YouTube Channel.
Targeting FOXO3 transcription factor as a Host-Directed approach to enhance the efficacy of
BCG against M.tb with Prof Makram Essafi
Here, Makram talks about his work on targeting the FOXO3 transcription factor as a host-directed approach to enhance the efficacy of BCG against Mycobacterium tuberculosis.
Vaccine against Human Leishmaniasis: Institut Pasteur de Tunis Contribution with
Prof Dhafer Laouini - Watch now on YouTube
In this talk, Dhafer describes the efforts made by Institute Pasteur de Tunis' scientists towards the development of a broadly protective anti-Leishmania vaccine.
- BSI public engagement funding: our updated grant scheme - Provides financial support to help BSI members develop and deliver activities to engage with the public in all formats - deadline 1 June 2023
- UKRI cross research council responsive mode pilot scheme - Funding for interdisciplinary ideas that transcend, combine or significantly span disciplines - deadline TBA
- NIH Global Infectious Disease Research Training Grants - Supports training related to diseases that are endemic in developing countries - deadline 3 August 2023
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
- Omic data analysis and visualisation using R, Online, 20 March 2023
- ADVAC - Advanced Course of Vaccinology, Les Pensières, Annecy, France, 8 May 2023
Find more event opportunities on our Training and Events pages.
- Biontec - Scientist - Tuberculosis Vaccine Development, Mainz, Germany, No stated deadline
Other relevant career opportunities are on our jobs page.
- Pre-sensitization with tuberculosis and non-tuberculosis mycobacteria and its impact on TB incidence in different age groups: Chengalpattu BCG trial revisited, Mohan P et al, in Tuberculosis
- Role of Treg, Breg and other cytokine sets in host protection and immunopathology during human leishmaniasis: Are they potential valuable markers in clinical settings and vaccine evaluation?, Francesca Divenuto F et al, Acta Tropica
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
News Medical shows that BCG does not protect the elderly from COVID-19, Precision Vaccines updated its list of TB vaccines for 2023, and Unite4TB promoted its Young Investigators Group. Kasturba Medical College is playing a leading role in India's National Task Force for Melioidosis, te APHA in the UK is field testing bovine TB vaccines, and India plans to develop a new TB vaccine by 2025. Medpage reported more scepticism about BCG's impact on COVID and GAVI reported on the positive economic impact of TB vaccines. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 8 February 2023